Health brief
Clinical AI Deployments and Post-War Welfare Audits
Sheba Medical Center expands clinical AI and European cancer care, while Bituah Leumi audits post-war trauma therapy fraud.
Health
Bituah Leumi is clawing back ₪15 million in fraudulent war therapy claims — cracking down on fake receipt schemes targeting post-October 7 rehabilitation aid.
BackgroundBituah Leumi launched emergency funding programs following October 7 to cover non-conventional rehabilitation therapies, including surfing and acupuncture, for traumatized citizens. Internal compliance audits were initiated to verify treatment receipts submitted by private service providers.
- Auditors uncovered organized rings issuing falsified receipts for luxury electronics and vacation travel disguised as alternative healthcare services.
- Bituah Leumi issued immediate repayment demands totaling ₪15 million to claimants involved in submitting fraudulent paperwork, marking its largest post-war welfare audit.
- Legitimate healthcare providers warned that blanket clawback demands risk penalizing genuine trauma victims who were unwitting targets of vendor fraud schemes.
Health
Soroka research proved outdoor smoking transfers harmful tobacco toxins indoors — causing sleep apnea and upper-airway obstruction in children.
BackgroundParents frequently assume that smoking outdoors or near open windows prevents indoor tobacco contamination and protects infants. Third-hand smoke consists of residual nicotine and chemical toxins that adhere to skin and clothing before off-gassing inside living spaces.
- Prof. Ariel Tarasiuk demonstrated that third-hand smoke particles travel indoors on parental clothing and skin, contaminating household air.
- Pediatric subjects exposed to third-hand smoke showed measurable sleep fragmentation and upper-airway obstruction during overnight clinical monitoring.
- Public health researchers urged pediatricians to update parental smoking cessation guidelines to explicitly highlight third-hand exposure risks.
Health
Sheba Medical Center partnered with OpenAI — becoming the first non-US hospital to integrate diagnostic AI models into live clinical care.
BackgroundRamat Gan-based Sheba Medical Center operates one of the world's leading medical innovation hubs, ARC, focused on scaling digital health technologies. Deploying frontier generative models in clinical settings requires rigorous patient privacy guardrails and protocol validation.
- Sheba surgical and diagnostic teams will access specialized OpenAI models to assist in real-time clinical decisions during complex procedure planning.
- The medical center will feed anonymized operational protocols back into OpenAI systems to refine clinical benchmarks for global deployment.
- The partnership establishes Sheba as the primary European and Israeli testing site for frontier healthcare AI tools in clinical environments.
Health
Sheba expanded access to melanoma cell therapy for European patients — filling a critical treatment void left by European regulatory delays.
BackgroundTumor-Infiltrating Lymphocyte therapy extracts and expands a patient's own cancer-fighting immune cells to attack advanced melanoma tumors. Sheba operates Israel's largest Good Manufacturing Practice biotherapy center, enabling full in-house production of personalized cell therapies.
- European melanoma patients face severe treatment shortages after commercial developers withdrew EMA regulatory filings due to market delays.
- Sheba's GMP biotherapy laboratory manufactures custom cell treatments directly on site in Ramat Gan for fast clinical deployment.
- International clinical access programs permit European patients to undergo specialized cellular immunotherapy treatments directly at Sheba.
Unlock the full brief
Sign in to read every signal, takeaway, and source. Free account — Apple, Google, or email.